SCHEMBL7904612

SCHEMBL7904612

COc1ccc(Cc2ccc(N3CCN(C(N)=O)CC3)nc2)c(F)c1-c1cccc(Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
HTR1A P08908 1/20 0.39
HTR2A P28223 1/20 0.39
HTR7 P34969 1/20 0.39
HTR6 P50406 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PDE4D Q08499 1/20 0.39
WNT3A P56704 1/20 0.39
F10 P00742 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
MGLL Q99685 1/20 0.38
MAPT P10636 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8065505 0.89 CXCR3 (0.42) ALDH1A1KDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL3792175 0.89 KDM4E (0.43) ALDH1A1KDM4ECYP1A2CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL3795473 0.88 CXCR3 (0.41) ALDH1A1KDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL3796449 0.88 CACNA1H (0.41) RAB9ASMN1; SMN2CACNA1H
SCHEMBL3786675 0.88 CNR2 (0.41) HTR7RAB9ASMN1; SMN2PDE4DCACNA1H
SCHEMBL3795599 0.86 HTR1A (0.42) HTR1AHTR2AHTR7HTR6RAB9A
SCHEMBL4322766 0.84 EGFR (0.39) SMN1; SMN2PDE4DF10GRM2
SCHEMBL4322265 0.84 EGFR (0.39) SMN1; SMN2PDE4DF10GRM2
SCHEMBL3794589 0.84 EGFR (0.39) SMN1; SMN2PDE4DF10GRM2
SCHEMBL3788894 0.84 TRPV1 (0.39) RAB9ASMN1; SMN2PDE4DCACNA1H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010059838-A2 PDE4 INHIBITORS SELECTIVE FOR THE LONG FORM OF PDE4 FOR TREATING INFLAMMATION AND AVOIDING SIDE EFFECTS DECODE GENETICS EHF (IS) 2010-05-27 WO disclosed